TARSUS PHARMACEUTICALS

Tarsus to Participate in Upcoming Investor Conferences

08 May 2025 17:00:00 By Nasdaq GlobeNewswire

Tarsus Reports First Quarter 2025 Financial Results and Recent Business Achievements

01 May 2025 16:05:01 By Nasdaq GlobeNewswire

Tarsus to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025

24 Apr 2025 17:00:00 By Nasdaq GlobeNewswire

Tarsus to Present Several Scientific Abstracts Highlighting the Global Prevalence of Demodex Blepharitis and the Clinical Impact of XDEMVY at the American Society of Cataract and Refractive Surgery (ASCRS) 2025 Annual Meeting

22 Apr 2025 08:31:11 By Nasdaq GlobeNewswire

Tarsus Announces Pricing of Upsized $125.0 Million Public Offering

12 Mar 2025 21:49:33 By Nasdaq GlobeNewswire

Tarsus Announces Proposed $100.0 Million Public Offering

12 Mar 2025 16:12:46 By Nasdaq GlobeNewswire

Tarsus to Participate in Upcoming Investor Conference

06 Mar 2025 17:00:00 By Nasdaq GlobeNewswire

Tarsus Reports Strong Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Achievements

25 Feb 2025 07:00:01 By Nasdaq GlobeNewswire

Tarsus to Report Fourth Quarter and Full-Year 2024 Financial Results on Tuesday, February 25, 2025

20 Feb 2025 17:00:00 By Nasdaq GlobeNewswire

Tarsus to Participate in Upcoming Investor Conferences

30 Jan 2025 17:00:00 By Nasdaq GlobeNewswire

Tarsus Provides 2025 Update: Accelerating the Launch of XDEMVY® and Establishing Ocular Rosacea as the Next Category-Creating Opportunity in Eye Care

13 Jan 2025 08:30:00 By Nasdaq GlobeNewswire

Tarsus Reports Third Quarter and Year-to-Date 2024 Financial Results and Recent Business Achievements

13 Nov 2024 16:05:00 By Nasdaq GlobeNewswire

Tarsus Welcomes Kate Goodrich, M.D., MHS, to its Board of Directors

13 Nov 2024 08:30:00 By Nasdaq GlobeNewswire

Tarsus to Report Third Quarter 2024 Financial Results on Wednesday, November 13, 2024

06 Nov 2024 16:30:00 By Nasdaq GlobeNewswire

Tarsus Appoints Elizabeth Yeu, M.D., as Chief Medical Officer

05 Nov 2024 08:30:00 By Nasdaq GlobeNewswire

Tarsus Launches “Your Mitey Problem,” the First Direct-to-Consumer TV Campaign for XDEMVY® (lotilaner ophthalmic solution) 0.25%

17 Oct 2024 08:30:00 By Nasdaq GlobeNewswire

Tarsus to Participate in Fireside Chat at UBS Virtual Ophthalmology Day 2024

25 Sep 2024 17:00:00 By Nasdaq GlobeNewswire

Tarsus to Participate in Fireside Chat at the 2024 Wells Fargo Securities Healthcare Conference

28 Aug 2024 17:00:00 By Nasdaq GlobeNewswire

Tarsus Reports Second Quarter and Year-to-Date 2024 Financial Results and Recent Business Achievements

08 Aug 2024 16:05:01 By Nasdaq GlobeNewswire

Tarsus to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024

29 Jul 2024 16:30:00 By Nasdaq GlobeNewswire